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Purpose: To investigate the immunomodulatory activity of the alcohol extract of Terminalia chebula Retz 
(Combretaceae) dried ripe fruits at the cellular level.  
Methods: For antioxidant study, the liver mitochondria were separated and used for the estimation of 
enzymes catalase (CAT) and superoxide dismutase (SOD) - as well as lipid peroxidation (LPO) and 
reduced glutathione (GSH); Melatonin secretion was characterized using sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) while spleen lymphocyte proliferation assay was 
performed by measuring optical density at 570 nm using ELISA reader. The cytokines, namely, IL-2, IL-
10 and TNF-α expression in spleen cells, were determined by real time polymerase chain reaction (RT-
PCR ) 
Results: Terminalia chebula extract (100 mg/kg/p.o.) increased the level of liver mitochondrial enzymes 
CAT and SO) as well as GSH but decreased the level of LPO in the liver when compared to the vehicle, 
sheep red blood cells (SRBC) and cyclophosphamide-treated groups. Secretion of melatonin by pineal 
gland was enhanced by T. chebula treatment.  The extract also increased spleen lymphocyte 
proliferation. Based on RT-PCR analysis, the expression of cytokines, viz, IL-2, IL-10 and TNF-α, was 
more in T. chebula-treated than in vehicle- and cyclophosphamide- treated groups.  
Conclusion: This study confirms the immunomodulatory activity of ripe T. chebula fruits as evidenced 
by increase in the concentration of antioxidant enzymes, GSH, T and B cells, the proliferation of which 
play important roles in immunity. This phenomenon also enhances the concentration of melatonin in 
pineal gland as well as the levels of cytokines, such as IL-2,IL-10  and TNF-α, which play  important 
roles in immunity. 
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INTRODUCTION 
 
Herbal medicine has become an integral part 
of standard healthcare, based on a 
combination of time-honoured traditional 
usage and ongoing scientific research. Rising 
interest in medicinal herbs has increased 
scientific scrutiny of their therapeutic 
potentials and safety. Some of the medicinal 
plants are believed to enhance the natural 
resistance of the body to infections [1].   
 
Immunostimulation and immunosuppression 
both need to be tackled in order to regulate 
normal immunological functioning. Therefore, 
stimulatory or suppressive agents which 
possess activity to normalize or modulate 
pathophysiological processes are called 
immunomodulatory agents. Among 
suppressive synthetic substances, 
cyclophosphamide has been extensively 
studied. However, the major drawback of this 
drug is myelosuppression, which is 
undesirable [2]. Moreover, natural adjuvants, 
synthetic agents and antibody reagents are 
used as immunomodulatory agents. 
Nevertheless, there are major limitations to 
the general use of these agents such as 
increased risk of infection and generalized 
effect throughout the immune system.  
 
There is a rise in the usage of herbal plants 
to treat diseases of the immune system over 
the last century. Besides, compared to 
synthetic drugs, herbal drugs are frequently 
considered to be less toxic and with fewer 
side effects. Therefore, the search for more 
effective and safer agents that exert 
immunomodulatory activity has intensified 
across the world [3]. 
 
In recent years, immunostimulatory activity 
has been reported in a number of Ayurvedic 
plants such as Tinospora cordifolia, Allium 
sativum, Andrographis paniculata, Picrorhiza 
kurroa [4] and Terminalia chebula. T. chebula 







radioprotective activities [5. In spite of its 
many therapeutic effects, to the best of our 
knowledge, no data are available on the 
immunomodulatory effect of the dry ripe fruits 
of Terminalia chebula at the cellular level. 
Thus, the objective of the present study was 
to assess the immunomodulatory potential of 
the alcohol extract of the dry ripe fruit of this 
plant at the cellular and molecular levels 




Plant material and preparation of extracts 
 
The ripe fruits of Terminalia chebula were 
identified by Dr GC Joshi (taxonomist), 
Regional Research Institute, Ranikhet, 
Uttarakhand, India. A voucher specimen (no. 
PHG/H/2132) has been preserved in the 
herbarium at the Pharmacognosy laboratory, 
College of Pharmacy, IFTM Moradabad for 
future reference. The fruits of T. chebula 
were shade-dried and coarsely powdered, 
335 g of which extracted with 1.5 L of 70 % 
ethanol for 32 h using a Soxhlet apparatus. 
The extract was concentrated to dryness 
under reduced pressure by rotary evaporator 
at 45 
0
C yielded 16 g of dry extract which was 
then preserved in a calcium chloride 




Male Wistar rats weighing 150 - 180 g were 
procured from Laboratory Animals 
Resources, Division of Animal Genetics, 
Indian Veterinary Research Institute (IVRI), 
Izatnager, Bairelly, India and acclimatized to 
laboratory conditions in the animal house of 
IFTM, Moradabad at room temperature with a 
12h/12h light/dark cycle and relative humidity 
of 60 ± 5 %. They had free access to 
standard pellet diet and water. The 
institutional animal ethical committee 
reviewed and approved (reg no. 837/ac/04) 
the protocol of the animal studies prior to 
commencement of the experiment. Allthe rats 
were treated in accordance with the National 
Institutes of Health’s Guidelines for the Care 
and Use of Laboratory. 
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Preparation of sheep red blood cells 
(SRBC) 
 
Blood from a healthy sheep, was collected 
from a local abbatoir, mixed thoroughly with 
sterile Alsever’s solution (1:1) and centrifuged 
at 3000 rpm for 5 min. The supernatant was 
discarded, and the SRBC pellets were 
washed thrice with sterile phosphate buffered 
saline (pH 7.2), re-suspended in phosphate 
buffered saline (pH 7.2). Total SRBC was 
counted using Neubauer chamber. SRBC 
(1x10
8
 cells, 0.5ml) was injected intraperi-
toneally to produce sensitization of the rats 
[6]. 
 
Treatment of animals  
 
The rats were divided into four groups of six 
rats each. Group I was negative control and 
treated with 2 ml of 1 % gum acacia solution 
in distilled water. Group II was positive 
control: where the rats (first sensitized by 
administering 1 x 10
8
 SRBC, i.p.) were 
treated with 1 % gum acacia solution orally. 
Group III rats were treated with 
cyclophosphamide (100 mg/kg, p. o). Group 
IV was sensitized rats treated with the extract 
(100 mg/kg, p.o.). The foregoing treatments 
were administered to Groups II and IV 4 days 
prior to sensitization (days -3, -2, -1, 0) where 
applicable, and for 7 days after sensitization 
(days +1, +2, +3, +4, +5, +6, +7) 
 
Assessment of immunological activity 
 
Immunostimulatory activity was examined 
using in vivo and in vitro immunological tests 
which are described below SIx hours after the 
last dose, the animals were sacrificed, the 
liver, pineal gland and spleen removed and 
their biochemical parameters determined as 
described in the following subsections. 
 
To isolate the mitochondria, 1 g of liver tissue 
was weighed, homogenized with 5 ml 0.35M 
sucrose buffer (pH 7.0) at 4 
0
C and 
centrifuged at 10,000 g for 5 min. The 
supernatant was discarded and the resultant 
pellet, which contained  mitochondria, was 
suspended in a mixture of 1 ml of 10mM Tris-
HCl (pH 7.4) solution and 0.2 ml of 1mM 
EDTA; the volume was made up to 2 ml with 
0.25M sucrose solution [7]. This solution was 
used for the determination of various 
mitochondrial antioxidant enzymes. 
 
Determination of lipid peroxidation (LPO) 
in homogenized liver tissue 
 
After sacrificing the animals, the liver was 
isolated, weighed, washed with chilled ice-
cold sterile 0.9 % NaCl solution. Tissue 
homogenate was prepared in a ratio of 1 g of 
wet tissue to 9 ml of 1.15 % KCl using a 
Teflon Potter-Elvehjem homogenizer [7]. 
 
The tissue homogenate (0.2 ml) was added 
to a mixture of 0.2 ml of 1% sodium dodecyl 
sulfate (SDS), 1.5 ml of 20 % acetic acid 
solution adjusted to pH 3.5 with NaOH, and 
1.5 ml of 0.8 % aqueous solution of 
thiobarbituric acid. The mixture was made up 
to 4 ml with distilled water, and then heated in 
an oil bath at 95 
0
C for 60 min using a glass 
ball as a condenser. After cooling the mixture 
in tap water, 1 ml of distilled water, and 5 ml 
of mixture of n-butanol and pyridine (15:1, 
v/v) were added and shaken vigorously. After 
centrifuging at 4000 rpm for 10 min, the 
organic layer was taken and the absorbance 
measured at 532nm (model UV-1240m 
spectrophotometer, Shimadzu, Japan). 1, 1, 
3, 3- tetramethoxypropane (TMP) was used 
as standard, and the content of LPO was 
expressed as nmol of malondialdehyde 
(MDA) [7]. 
 
Reduced glutathione (GSH) 
 
Mitochondrial GSH was estimated by adding 
0.2 ml of mitochondrial enzyme solution  to 
1.8 ml distilled water followed by the addition 
of 3 ml precipitating mixture (0.0501g 
metaphosphoric acid, 0.006 g EDTA and 0.9 
g NaCl in 3ml distilled water). It was 
centrifuged at 5000 g for 5 min, and 1 ml of 
the supernatant was collected, mixed first 
with 1.5 ml of phosphate buffer  solution  (pH 
7.6) and then with 0.5 ml of 5,5’-dithio-bis -2-
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nitrobenzoic acid (DTNB) reagent. The 
optical density at 412 nm.was measured 
spectrophotometrically and expressed in 




Mitochondrial enzyme solution (0.2 ml) was 
added to a cuvette containing 2 ml of 
phosphate buffer (pH 7) and 1 ml of 30mM 
H2O2. Catalase activity was measured 
spectrophotometrically (UV-1240 Shimadzu, 
Japan) at 240 nm for 1 min. The molar 




was used to determine catalase activity. One 
unit of activity is equal to one millimole of 
H2O2 degraded per minute and is expressed 
as units/mg of protein [7]. 
 
Superoxide dismutase (SOD) 
 
Mitochondrial enzyme solution (50µL) was 
added to a mixture of 0.5 ml of 75 mM Tris- 
HCl buffer (pH 8.2), 1 ml of 30 mM EDTA and 
1ml of 2mM pyrogallol. Absorbance was 
recorded at 420 nm for 3 min using a 
spectrophotometer. One unit of enzyme 
activity was calculated as 50 % inhibition of 
the rate of auto-oxidation of pyrogallol as 
determined by a change in absorbance/min 
at 420 nm. The activity of SOD was 
expressed as units/mg protein [7]. 
 
Sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE)  
 
Protein fractions were isolated from the 
pineal glands of animals of each group and 
subjected to SDS-PAGE analysis for the 
detection of melatonin secretion. For this, the 
resolving gel mixture and stacking gel mixture 
used were 12 % resolving gel and 5 % 
stacking gel, respectively. The gels were 
stained using Coomassie Brillant Blue R-250 
solution for 4 h and then kept in destaining 
solution for 8 h until the background was 
colourless. Finally, after taking their 
photographs, the gels were stored in distilled 
water containing 20 % glycerol pending 
further study [8]. 
Lymphocyte proliferation assay  
 
Splenocyte single cell suspension was 
prepared by up-downing 4 ml RPMI-1640 in 
spleen and after omitting RBCs using 0.75 % 
NH4Cl in Tris buffer (0.02 %, pH 7.2) Six 
milliters of the buffer was added to 2 ml of the 
cell suspension and centrifuged at 1000 g for 
2 min). The concentration was adjusted to 2 x 
10
6
 cells/ml in RPMI-1640 supplemented with 
10 % fetal calf serum, 2 mM L-glutamine, 25 
mM (4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid) (HEPES). The diluted cell 
suspension (100 µl) was dispensed into a 96-
well flat bottom culture plate. Mitogen 
phytohemmaglutinin A (PHA) was added at a 
final concentration of 5 µg/ml to each well 
and the volume adjusted to 0.2 ml. Following 
incubation for 72 h at 37 
0
C and 5 % CO2 
humid atmospheric air, cell proliferation was 
determined by MTT assay method.  A 
solution (10 %) of 3-(4, 5 dimethyl-2-thiazolyl) 
2, 5-diphenyl-2H-tetrazolium (MTT, 5 mg/ml) 
was added to each well and the plate 
incubated at 37 
0
C in a CO2 humid 
atmosphere for 4 h The blue formazan 
precipitate formed was dissolved in acidic 
isopropanol (0.1M HCl in absolute 
isopropanol) and its optical density measured 
at 570 nm using ELISA Reader. Stimulation 
index (SI) was calculated as in Eq 1 [9].  
 
SI = ODSC/ODUC ………………… . (1) 
 
where ODSC is the optical density of the 
stimulated cells and ODUC is the optical 
density of unstimulated cells 
 
Real Time PCR (RT--PCR) for 
determination of IL-2, IL-10 and TNF-α 
expression  
 
Spleen cell suspension was prepared and 
used for the determination of cytokines IL-2, 
IL-10 and TNF- α. The sequences of primers 




Trizol LS reagent (Invitrogen, cat no. 10296-
010) Foster City, California, USA, was used 
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for RNA isolation using the method 
prescribed by the manufacturer. Briefly, 
spleen cells were washed with PBS, lysed by 
adding Trizol LS reagent to them and mixed 
by repeated pipetting.  The organic and 
aqueous phases were separated with the aid 
of chloroform (0.2 ml) and centrifugation at 
12000 g for 15 min. at 4 ºC. Total RNA in the 
aqueous phase was precipitated with 0.5 ml 
isopropyl alcohol, washed in 75  % ethanol 
(1ml), air-dried and diluted in 50 µl nuclease-
free water. 
 




Complementary DNA (cDNA) preparation 
 
Revert Aid M-MuLV Reverse Transcriptase 
(cat no. EP0441, Fermentas, Lithua-
nia, Europe) was used for this purpose.  
About 100 ng RNA (accurately weighed) and 
0.5 µg oligo dT primer (Invitrogen, cat no. 
18418-012) were mixed and snap-chilled. To 
this, was added 4 µl of 5× reaction buffer, 20 
U of RNase inhibitor, 2 µl of 10 mM dNTP 
and 200 U of Revert Aid M-MuLV Reverse 
Transcriptase. The final reaction volume was 
kept at 20 µl and incubated at 42 
o
C for 1 h. 
The reaction was then stopped by heating the 
mixture at 70 
0
C for 10 min. The resulting 
cDNA was divided into aliquots of suitable 
size and stored at -20 °C [10]. 
 
Real-time PCR studies 
 
Brilliant SYBR Green QPCR Core Reagent 
Kit (Stratagene, Santa Clara, CA -USA cat 
no. 600546) was used for this purpose. One 
microliter of cDNA was added to 11 µl of 
nuclease free water, 2.5 µl of 10× core PCR 
buffer, 1.25 µl 50 mM MgCl2 solution, 1 µl 20 
mM dNTP mix, 1 µl (12.5 pM/µl) of forward 
primer, 1 µl (12.5 pM/µl) of reverse primer, 4 
µl of 50 % glycerol solution, 0.75 µl of 100 % 
dimethyl sulfoxide (DMSO), 1.25 µl of 1:3000 
diluted SYBR Green I dye and 0.25 µl (1.25 
U) of SureStart Taq DNA polymerase. Real-
time PCR was carried out in Mx3000p 
(Stratagene Santa Clara, CA -USA). The 
thermal profile used for this is as follows: 95 
0
C for 10 min then 40 cycles of 95 
0
C for 30 s, 
64 
o
C for 30 s and 72 
0
C for 30 s with 
fluorescence recording at the end of each 
cycle, followed by denaturation of products 
from 55 to 95 
o
C with fluorescence recording 
throughout the step. Fold changes in target 
transcript levels were determined using the 
relationship: Etarget = Eref = 2. Glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) gene 




The data were expressed as mean ± 
standard deviation (SD) and statistical 
evaluation of the data was done using Prism 
software (version 5.00 GraphPad Software, 
Inc.USA). Data were tested for statistical 
significane using Students t-test, and 





Rat liver oxidative stress parameters 
 
Table 2 shows increased lipid peroxidation 
level in the liver of SRBC-treated group 
(98.38 ± 1.14 nmolMDA/g Hb)compared to 
vehicle treated rat (83.85 ± 2.12 nmol MDA/g 
Hb). Furthermore, cyclophosphamide-treated  



























RT-BGF CATGTTTGTGATGGGCGTGAACCA 24 
RT-BGR TAAGTCCCTCCACGATGCCAAAGT 24 
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Table 2: Effect of T. chebula extract on rat liver oxidative stress parameters 
 
Rat liver oxidative stress parameters  











Vehicle 83.85±2.12 4.22±0.21 22.22±0.10 271.31±3.2 
SRBC-sensitized 98.38±1.14 2.13±0.18 19.48±0.16 252.22±2.5 
CP 90.42±2.13 2.31±0.38 20.38±0.18 256.29±3.8 
T. chebula 68.01±1.16* 4.50±0.81* 25.36±0.21* 273.32±3.2* 
*P < 0.05 compared with SRBC-sensitized and cyclophosphamide (CP)-treated groups 
 
rats showed an increase (90.42 ± 2.13 
nmolMDA/g Hb) in lipid peroxidation level in 
the liver but after T. chebula extract 
treatment, the elevated lipid peroxidation 
decreased to 68.01 ± 1.16 nmol MDA/g Hb.  
 
The level of reduced glutathione, superoxide 
dismutase while catalase decreased on 
SRBC sensitization but was increased on 
treatment with T. chebula extract. The levels 
of reduced glutathione, superoxide dismutase 
and catalase on SRBC sensitization and 
extract treatment were 2.13 ± 0.18 and 4.50 ± 
0.81 µMol/g Hb; 19.48 ± 0.16 and 25.36±0.21 
units/mg protein; and 252.22 ± 2.5 0 and 
273.32 ± 3.2 units/mg protein, respectively. 
Cyclophosphamide produced immunosupre-
ssion by increasing lipid peroxidation and 
decreasing the levels of reduced glutathione, 
superoxide dismutase and catalase (p < 
0.05) when compared to the control group. 
 
Separation of pineal proteins  
 
A thick band at 248 kDa appeared in the 
group treated with the extract (lane 2) 
indicates a higher secretion of melatonin 
(Mol. Wt. 248 kDa).  In the SRBC-sensitized 
group, the expression of proteins was less 
(lane 4) than the control group (lane 3). The 
immunosuppressant, cyclophosphamide, 
showed the least expression of proteins 
compared to the other groups   (lane 5). The 
increased expression of melatonin in lane 2 
confirms the immunomodulatory activity of 




Figure 1: SDS-PAGE of rat pineal gland. Lane 1: 
Indicates the protein marker of the standard; Lane 
2: T. chebula extract treatment shows thick band 
of protein expression (248kDa) indicating the 
increased secretion of melatonin via pineal gland 
due to immunomodulatory action; Lane 3: Control 
group; Lane 4: SRBC-sensitized group; Lane 5: 
Immunosupression action of cyclophosphamide.  
 
Lymphocyte proliferation  
 
Table 3 shows that administration of the 
extract increased spleen lymphocytes 
proliferation (1.332 ± 0.214) compared to the 
control (0.787 ± 0.256) and cyclophos-
phamide-treated rats (0.832 ± 0.471) 
Phytohaemagglutininproduced proliferation of 
lymphocytes in all the groups.  
 
Table 3: Proliferation of rat spleen lymphocytes in 
response to antigen from the extract  
 




Vehicle 0.787±0.256 1.222±0.841 
CP 0.832±0.471 0.936±0.412 
T. chebula 1.332±0.214* 1.233±0.514* 
*P < 0.05 compared with control and cyclophosphamide 
(CP)-treated groups 
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IL-2, IL-10 and TNF-α gene expression in 
rat spleen mRNA  
 
Measuring and assessing cytokine profile 
provides a useful method for accurate study 
of the cytokines such as IL-2, IL-10 and TNF-
α. Table 4 shows that extract treatment 
increased the levels ofIL-2, IL-10 and TNF- α 
mRNA several fold (7.46-, 73.52- and 6.23-
fold, respectively) compared to control, 
cyclophosphamide and SRBC-sensitized 
groups. Increased expression in mRNA levels 
by the extract confirms its immunostimulant 
action.  
 
Table 4: Effect of different treatments on IL-2, IL-
10 and TNF-α gene expression 
 
Fold-change in IL-2, IL-
10 and TNF- α mRNA 
level 
Treatment 
IL-2 IL-10 TNF-α 
Vehicle (Control)  1.00 1.00 1.00 
CP* 6.41 8.63 -1.78 
T. chebula 7.46 73.52 6.23 
SRBC sensitized -2.87 22.63 1.18 




Oxidation of membrane lipid molecules 
causes damage resulting in the development 
of several physiological and pathological 
disorders. Inhibition of lipid peroxidation is the 
best way to avoid these disorders in the body 
[11]. The present study shows that T. chebula 
alcohol extract inhibited lipid peroxidation 
compared to treatment with SRBC and 
cyclophosphamide.  
 
Glutathione is the major endogenous 
antioxidant produced by cells. It participates 
directly in the neutralization of free radicals 
and reactive oxygen compounds, as well as 
maintenance of exogenous antioxidants, 
such as vitamins C and E, in their reduced 
(active) forms. Through direct conjugation, it 
detoxifies many xenobiotics (foreign 
compounds) and carcinogens, both organic 
and inorganic [12]. It is essential for the 
immune system to exert its full potential, viz, 
modulating antigen presentation to 
lymphocytes, thereby influencing cytokine 
production; enhancing proliferation of 
lymphocytes and hence increasing the 
magnitude of response; and  increasing the 
killing activity of cytotoxic T cells and natural 
killer cells, and regulating apoptosis, thereby 
maintaining control of the immune 
response[13]. Glutathione plays a 
fundamental role in numerous metabolic and 
biochemical reactions such as DNA synthesis 
and repair, protein synthesis, prostaglandin 
synthesis, amino acid transport and enzyme 
activation. Thus, every system in the body, 
especially the immune, nervous, and 
gastrointestinal systems, as well as the lungs, 
can be affected by the level of glutathione. 
[14]. 
 
Superoxide dismutase induces the activation 
of endogenous system of antioxidant 
defences which fights against free radicals. 
 
It 
is known that superoxide dismutase plays an 
important role in the detoxification of 
superoxide anion and H2O2, thereby 
protecting the cell against free radical-
induced damage [12].  
 
Catalase is an antioxidant enzyme that helps 
in neutralizing the toxic effect of H2O2. 
Hydrogen peroxide is not reactive enough to 
cause a chain of lipid peroxidation reactions, 
but its combination with superoxide radical 
produces hydroxyl radicals that are highly 
reactive and thus initiate lipid oxidation 
reaction [15]. This lipid peroxidation damages 
the cell membrane resulting in the 
development of several physiological and 
pathological disorders. Catalase prevents this 
by conversion of hydrogen peroxide to water 
and non-reactive oxygen species,thereby 
preventing the generation of hydroxyl radical 
and protecting the cell from oxidative damage 
[16]. Our studies showed that there was 
distinct increase in the levels of glutathione, 
superoxide dismutase and catalase following 
treatment with T. chebula as alcohol extract 
compared to treatment with SRBC and 
cyclophosphamide. Therefore, the extract 
has both antioxidant as well and 
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immunomodulatory activities, and is thus 
capable of protecting cells from oxidative 
damage.  
 
Melatonin plays an important role as an 
immunomodulator, as well as performing 
other physiological functions.  It has been 
reported to be an integral part of the immune 
system, and exerts direct and/or indirect 
stimulatory effect on both cellular and 
humoral immunity [17]. The present study 
showed that treatment with T. chebula 
caused the expression of a thick band of 
protein, indicating increased production of 
melatonin. Hence, T. chebula extract exhibits 
immunostimulant action by enhancing 
melatonin secretion in the pineal gland.  
 
Earlier workers have shown that drugs having 
immunomodulatory activity show enhanced 
proliferation of splenocytes [18].  In the 
present study, the extract significantly 
enhanced the proliferation of splenocytes 
Proliferation of lymphocytes indicates 
increase in the number of β and T cells, 
which release cytokines and growth factors 
that regulate other immune cells and 
secretion of antibodies in the blood [19].  
 
Cytokines are released by living cells of the 
host in a highly regulated fashion to regulate 
cell functions via specific receptors which 
participate in the control of all 
immunologically relevant events, whether 
they concern the activation, differentiation, 
maturation, proliferation, apoptosis, or 
acquisition of effector functions. Cytokines 
influence the quantitative, as well as the 
qualitative outcome of immune response [20]. 
In our study, administration of T. chebula 
extract to rats showed significant 
immunomodulatory activities as reflected by 
marked changes in IL-2, IL-10 and TNF-α 
mRNA levels. IL-2 shows immunomodulatory 
activities through T and β lymphocytes 
proliferation, natural killer cell activation [20-
21]
 
and increased immunoglobulin G 
production whereas IL-10 promotes elevation 
of Th2 cells [20-22] and TNF-α modulates 
cytokine gene expression [20].  Thus, the 
immunomodulatory activity of T. chebula may 





The immunomodulatory activity of T. chebula 
may be by inhibition of lipid peroxidation and 
increased levels of antioxidant enzymes catalase 
and superoxide dismutase; increased melatonin 
secretion by pineal gland which play a role in 
immunomodulatory action by exerting direct 
and/or indirect stimulatory effect on both cellular 
and humoral immunity; and proliferation of 
lymphocytes as indicated by the increase in the 
number of β and T cells which release cytokines 
and growth factors that regulate other immune 
cells and secretion of antibodies in the blood. 
Other mechanisms such as increased levels of 
cytokinesIL-2, IL-10 and TNF-α which play 
important role in immunomodulatory actions such 
as T and B lymphocyte proliferation, natural killer 
cell activation, elevation of Th2 cells and 
modulation of cytokine gene expression also 
seem to be in operation. However, further 
investigations are required to isolate the active 
constituents responsible for these activities and 
to elucidate in detail the cellular and molecular 
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